Millicent Pharma is a pharmaceutical company whose U. S. website provides information and patient support for INTRAROSA, a prescription vaginal insert distributed in the United States by Millicent U.

S. Inc. INTRAROSA is indicated for women after menopause who experience moderate to severe pain during sexual intercourse caused by menopausal changes in and around the vagina.

Its active ingredient, prasterone, is derived from a plant-based form of DHEA; the body converts it into androgens and estrogens. The product is used once daily at bedtime, and clinical trial information on the site reports reduced pain during sex after 12 weeks of use. The website explains how INTRAROSA differs from lubricants, provides prescribing and patient information, and offers answers to frequently asked questions.

It also outlines savings programs for eligible commercially insured and Medicare-eligible patients. The site presents important safety information, including cautions about unexplained vaginal bleeding and breast cancer history, and notes that common side effects include vaginal discharge and changes on a Pap smear